The global healthcare electronic data interchange market size is calculated at USD 5.85 billion in 2025 and is forecasted to reach around USD 13.38 billion by 2034, accelerating at a CAGR of 9.62% from 2025 to 2034. The North America market size surpassed USD 2.40 billion in 2024 and is expanding at a CAGR of 9.63% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Healthcare Electronic Data Interchange Market Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Healthcare Electronic Data Interchange Market, by Component
8.1.1 Services
8.1.1.1. Market Revenue and Forecast
8.1.2. Solutions
8.1.2.1. Market Revenue and Forecast
9.1. Healthcare Electronic Data Interchange Market, by Delivery Mode
9.1.1. Web and Cloud-based EDI
9.1.1.1. Market Revenue and Forecast
9.1.2. EDI Value Added Network (VAN)
9.1.2.1. Market Revenue and Forecast
9.1.3. Direct (Point-to-Point) EDI
9.1.3.1. Market Revenue and Forecast
9.1.4. Mobile EDI
9.1.4.1. Market Revenue and Forecast
10.1. Healthcare Electronic Data Interchange Market, by End-Use
10.1.1. Healthcare Payers
10.1.1.1. Market Revenue and Forecast
10.1.2. Healthcare Providers
10.1.2.1. Market Revenue and Forecast
10.1.3. Pharmaceutical & Medical Device Industries
10.1.3.1. Market Revenue and Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Component
11.1.2. Market Revenue and Forecast, by Delivery Mode
11.1.3. Market Revenue and Forecast, by End-Use
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component
11.1.4.2. Market Revenue and Forecast, by Delivery Mode
11.1.4.3. Market Revenue and Forecast, by End-Use
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component
11.1.5.2. Market Revenue and Forecast, by Delivery Mode
11.1.5.3. Market Revenue and Forecast, by End-Use
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component
11.2.2. Market Revenue and Forecast, by Delivery Mode
11.2.3. Market Revenue and Forecast, by End-Use
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component
11.2.4.2. Market Revenue and Forecast, by Delivery Mode
11.2.4.3. Market Revenue and Forecast, by End-Use
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component
11.2.5.2. Market Revenue and Forecast, by Delivery Mode
11.2.5.3. Market Revenue and Forecast, by End-Use
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component
11.2.6.2. Market Revenue and Forecast, by Delivery Mode
11.2.6.3. Market Revenue and Forecast, by End-Use
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component
11.2.7.2. Market Revenue and Forecast, by Delivery Mode
11.2.7.3. Market Revenue and Forecast, by End-Use
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component
11.3.2. Market Revenue and Forecast, by Delivery Mode
11.3.3. Market Revenue and Forecast, by End-Use
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component
11.3.4.2. Market Revenue and Forecast, by Delivery Mode
11.3.4.3. Market Revenue and Forecast, by End-Use
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component
11.3.5.2. Market Revenue and Forecast, by Delivery Mode
11.3.5.3. Market Revenue and Forecast, by End-Use
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component
11.3.6.2. Market Revenue and Forecast, by Delivery Mode
11.3.6.3. Market Revenue and Forecast, by End-Use
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component
11.3.7.2. Market Revenue and Forecast, by Delivery Mode
11.3.7.3. Market Revenue and Forecast, by End-Use
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component
11.4.2. Market Revenue and Forecast, by Delivery Mode
11.4.3. Market Revenue and Forecast, by End-Use
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component
11.4.4.2. Market Revenue and Forecast, by Delivery Mode
11.4.4.3. Market Revenue and Forecast, by End-Use
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component
11.4.5.2. Market Revenue and Forecast, by Delivery Mode
11.4.5.3. Market Revenue and Forecast, by End-Use
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component
11.4.6.2. Market Revenue and Forecast, by Delivery Mode
11.4.6.3. Market Revenue and Forecast, by End-Use
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component
11.4.7.2. Market Revenue and Forecast, by Delivery Mode
11.4.7.3. Market Revenue and Forecast, by End-Use
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component
11.5.2. Market Revenue and Forecast, by Delivery Mode
11.5.3. Market Revenue and Forecast, by End-Use
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component
11.5.4.2. Market Revenue and Forecast, by Delivery Mode
11.5.4.3. Market Revenue and Forecast, by End-Use
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component
11.5.5.2. Market Revenue and Forecast, by Delivery Mode
11.5.5.3. Market Revenue and Forecast, by End-Use
12.1. OSP
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. MCKESSON CORPORATION
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. NXGN Management, LLC
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Optum, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Epicor Software Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. SSI Group LLC
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cleo
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Oracle
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Effective Data
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. DataTrans Solutions
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample